JZL195 is a selective and efficacious dual fatty acid amide hydrolase ( FAAH ) and monoacylglycerol lipase ( MAGL ) inhibitor with IC 50 s of 2 and 4 nM, respectively.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Pain | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > FAAH | Products > Signaling Pathways > MAGL | Products > Signaling Pathways > Autophagy
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.